BioMark Diagnostics Inc.
BUX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.11M | 1.54M | 1.73M | 61.60K | 25.60K |
| Total Receivables | 126.60K | 124.60K | 111.80K | 49.20K | 49.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.24M | 1.66M | 1.84M | 110.80K | 75.60K |
|
|
|||||
| Total Current Assets | 1.24M | 1.66M | 1.84M | 110.80K | 75.60K |
| Net Property, Plant & Equipment | 73.20K | 260.70K | 315.90K | 472.50K | 546.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.20K | 25.00K | 24.10K | 23.70K | 25.30K |
| Total Assets | 1.35M | 1.95M | 2.18M | 609.30K | 649.80K |
|
|
|||||
| Total Accounts Payable | 148.30K | 213.30K | 186.10K | 330.60K | 307.80K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 463.70K | 489.50K | 461.50K | 656.10K | 631.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 95.80K | 189.30K | 204.20K | 64.20K | 134.30K |
| Total Finance Division Other Current Liabilities | 6.00K | 6.10K | 5.80K | 5.80K | 6.20K |
| Total Other Current Liabilities | 6.00K | 6.10K | 5.80K | 5.80K | 6.20K |
| Total Current Liabilities | 713.90K | 898.20K | 857.60K | 1.06M | 1.08M |
|
|
|||||
| Total Current Liabilities | 713.90K | 898.20K | 857.60K | 1.06M | 1.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 463.70K | 489.50K | 461.50K | 656.10K | 631.00K |
| Capital Leases | 14.20K | 74.10K | 111.80K | 315.60K | 336.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 728.00K | 972.40K | 969.40K | 1.37M | 1.42M |
|
|
|||||
| Common Stock & APIC | 12.59M | 12.85M | 12.19M | 9.19M | 9.78M |
| Retained Earnings | -11.97M | -11.87M | -10.97M | -10.67M | -11.12M |
| Treasury Stock & Other | -- | -- | -- | 716.10K | 573.60K |
| Total Common Equity | 619.90K | 976.00K | 1.21M | -763.00K | -765.70K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 619.90K | 976.00K | 1.21M | -763.00K | -765.70K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 619.90K | 976.00K | 1.21M | -763.00K | -765.70K |
|
|
|||||